Prognostic significance of routine clinical and laboratory data in advanced head and neck cancers

Anticancer Research

Volumn 16, Issue 2, 1996, Pages 1005-1010

  Himberlin, C H ^a   Merol, J C ^d   Nasca, S ^a   Panis, X ^b   Lebrun, D ^a   Desoize, B ^c   Legros, M ^d   Coninx, P ^a,c  

^a Serv de Med Interne Oncologique   (France)

^b Polyclinique de Courlancy   (France)

^c INSTITUT JEAN GODINOT   (France)

^d Chirurgie de la Face et du Cou   (France)

Author keywords

Chemotherapy; Drug monitoring; Head and neck cancer; Prognosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINEOPLASTIC ANTIMETABOLITE; ANTINEOPLASTIC METAL COMPLEX; CISPLATIN; CREATININE; FLUOROURACIL; HEMOGLOBIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CREATININE BLOOD LEVEL; DIARRHEA; HEAD AND NECK CANCER; HUMAN; MULTIVARIATE ANALYSIS; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTOPENIA; VOMITING; WEIGHT REDUCTION;

ADULT; AGED; ALANINE TRANSAMINASE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HEMOGLOBINS; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS;

EID: 0029899080     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Bachaud J, David J, Shubinski R, Perineau D, Boussin G, Serrano E, De Forni M, Pessy J, Daly Schveitzer N: Predictive factors of a complete response to and adverse effects of a CDDP-5FU combination as primary therapy for head and neck squamous cell carcinomas. J Laryngo Oto 107: 924-930, 1993.
2. Kish J, Drelichman A, Jacobs J, Hoschner J, Kinzie J, Loh J, Weaver A, Al-Sarraf M : Clinical trial of cisplatin and 5-FU infusion as initial treatment for advanced squamous cell carcinoma of head and neck. Cancer Treat Rep 60: 471-474, 1982.
3. Coninx P, Nasca S, Lebrun D, Panis X Lucas P, Garbe E, Legros M: Sequential trial of initial chemotherapy for advanced cancer of the head and neck. Cancer 62: 1888-1892, 1988.
4. Cockroft D and Gault H: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41, 1976.
5. Bannister S, Chang Y, Sternson L, Repta A: Atomic absorption spectrophotometry of free circulating platinum species in plasma derived from cis-dichlorodiammineplatinum (II). Clin Chem 24: 877-880, 1978.
6. Kind P, Gordon M, Laverick M, Nias M, Slavin B: The effect of C3H mouse mammary tumor on the levels of serum and urine analytes, in vivo. Br J Cancer 52: 607-612, 1985.
7. Liautaud-Roger F, Desoize B, Mili H, Carpentier Y, Delvincourt Ch, Coninx P: Enzymes seriques et triglycerides chez les souris porteuses d'une tumeur mammaire. Path Biol 35: 1119-1122, 1987.
8. Maran A, Wilson J, Gaze M: The nature of the head and neck cancer. Eur Arch Oto-Rhino-Laryngol 250: 127-132, 1993.
9. Hemmer J, Kreidler J, Van Heerden W, Raubenheimer E, Schon E: Flow cytometric cellular DNA content and lymph node metastasis in squamous cell carcinoma of the oral cavity. Int J Oncol 6: 1237-1242, 1995.
10. Snyderman C, Heo D, Johnson J, D'Amico F, Barnes L, Whiteside T: Functional and phenotypic analysis of lymphocytes in head and neck cancer. Arch Otolaryngol Head-Neck Surg 7: 899-905, 1991.
11. Wustrow T: Interleukin 2 secretion with squamous cell cancer of the oropharynx or larynx. Laryngorhinootologie 68: 110-117, 1989.